Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACHA: Minocycline for Intracerebral Hemorrhage Absorption
NCT05630534Phase 1Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of minocycline in intracerebral hemorrhage (ICH) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: modified Rankin Scale score at 90 days. Status: unknown.
02
Drugs
minocycline
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT05630534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05630534.